Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment
With Northway Biotech's expertise in biologics manufacturing, Mallia aims to enter the multi-billion-dollar alopecia market by delivering a safe and effective topical sCD83 treatment designed to stimulate hair follicle formation and promote sustained hair growth.
ERLANGEN, GERMANY AND VILNIUS, LITHUANIA / ACCESS Newswire / February 4, 2025 / Mallia Therapeutics ("Mallia"), a biopharmaceutical company developing novel treatments for hair loss, and Northway Biotech ("NBT"), a biologics Contract Development and Manufacturing Organization (CDMO), have announced a partnership for the development of the production process and manufacturing of Mallia's soluble CD83 protein (sCD83), a treatment aimed at promoting hair follicle formation and growth.
Under the agreement, Northway Biotech will leverage its expertise in biologics manufacturing to develop the production process for the recombinant sCD83 protein for large-scale production, utilizing the Pichia pastoris expression system. This collaboration includes the development of analytical methods, technology scale-up, and the manufacturing of a cGMP Drug Substance.
Dr. Manfred Groeppel, co-founder and Managing Director of Mallia Therapeutics, said: "With this partnership, we are advancing the development of sCD83 to turn our research into a scalable treatment for patients."
"Interestingly, sCD83's mode of action induces both the formation of new hair follicles and thus hair growth, and has the potential to redefine treatment approaches for hormone-induced androgenetic alopecia as well as immune-mediated alopecia areata," emphasizes Prof. Dr. Alexander Steinkasserer, co-founder and Managing Director of Mallia. "By developing a robust production process, we are ensuring the quality required for future clinical as well as commercial applications."
Prof. Vladas Algirdas Bumelis, CEO and Chairman of Northway Biotech, expressed, "We are excited to be working with Mallia on developing the manufacturing process of sCD83. Our priority is to ensure the highest manufacturing standards and maintain clear, open communication as we collaborate every step of the way."
"Mallia's team and their innovative solution make this project particularly appealing to us given its huge potential and the large need from people all over the world for treatment. The strong and transparent collaboration we have established allows us to support Mallia with confidence as we move forward together quickly,"added André Markmann, PhD, VP of Business Development at Northway Biotech.
About Mallia Therapeutics GmbH
Mallia Therapeutics GmbH is a biopharmaceutical company focused on developing novel treatments for patients suffering from hair loss. The Company was founded in 2023 in Erlangen, Germany, and is led by an experienced management team and worldwide leading experts in the field of CD83, with more than 60 CD83-related publications and 20 years of experience in the field.
With sCD83, a potential treatment for hair loss in preclinical development, Mallia aims to enter the multi-billion-dollar alopecia market and provide patients with a safe and effective topical treatment.
Connect with us on LinkedIn or find out more here: https://mallia-therapeutics.com/
About Northway Biotech
Northway Biotech is a leading contract development and manufacturing organization (CDMO) supporting customers worldwide. Its highly experienced and professional team executes projects at every stage, from cell line construction and process development to cGMP manufacturing of biopharmaceutical products. The company's extensive expertise and vertically integrated service offering enable rapid execution of multiple projects from its state-of-the-art GMP facilities while ensuring full process and product compliance at all stages of research, development, and commercial manufacturing. Northway Biotech is a privately owned company founded in 2004 and operates locations in Vilnius, Lithuania; London, United Kingdom; and Waltham, MA, USA. For more information, please visit www.northwaybiotech.com.
Mallia Therapeutics Contact:
Mallia Therapeutics GmbH
info@mallia-therapeutics.com
International Media Contact:
MC Services AG
Dr. Regina Lutz / Katja Arnold
Tel.: +49 (0)89 210 228 0
E-Mail: mallia-therapeutics@mc-services.eu
Contact Information
Vladas Bumelis
CEO and Chairman of the Board
vladas.bumelis@northwaybiotech.com
SOURCE: Northway Biotech
View the original press release on ACCESS Newswire
Northway Biotech
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AWM Wraps Up 2025 with Multiple Surf Venue Grand Openings16.12.2025 16:05:00 CET | Press Release
Ending the Year on a High Note SOLANA BEACH, CA / ACCESS Newswire / December 16, 2025 / American Wave Machines, the surf technology company behind PerfectSwell® Surf Venues worldwide, concludes banner year with two grand openings and expansion into new markets. São Paulo Surf Club Key Year End Highlights: Riyue Bay: November 11 China Tourism Group celebrated the grand opening of PerfectSwell® Riyue Bay Surf Resort Zion: November 20 The Foundation Ceremony of PerfectSwell® Zion took place in Utah. São Paulo: November 29 JHSF celebrated the grand opening of São Paulo Surf Club "This year's results reflect a herculean effort from the team on improving efficiency, product delivery and commissioning. Finishing with two grand openings in one month is perhaps our most notable achievement. With PerfectSwell® Zion well underway and a third pool starting up in Brazil, 2026 will be just as memorable." - CEO Bruce McFarland "The wave quality achievements made this year have exceeded the expectatio
Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards16.12.2025 15:00:00 CET | Press Release
MIAMI, FLORIDA / ACCESS Newswire / December 16, 2025 / AstraZeneca, Eastman, Kraft Heinz, and P&G have been recognized for their outstanding contribution at the recent OMP Conference. The four industry leaders were honored at the Miami event for their commitment to innovation and excellence, while driving real-world results across their global operations. The OMP Awards program turns the spotlight on organizations within the OMP Community that set new benchmarks in supply chain planning and inspire cross-industry progress and transformation. Eastman: Co-shaping Unison Planning™ in a long-term partnership A strategic OMP customer for nearly two decades, Eastman received the Long‑Term Partnership Award for co‑shaping the chemical industry solution of Unison Planning™. Eastman's vision and intense collaboration have helped redefine best practices in chemical supply chain planning and have been a positive influence on broader industry standards. Accepting the award, Baptiste Lebreton, Digi
The U.S. Polo Assn. Palm Beaches Marathon Celebrates Record-Breaking Weekend in West Palm Beach, Florida16.12.2025 13:00:00 CET | Press Release
Thousands of Runners From Around the World Participate in South Florida Race Weekend, With Ivan Gabriel Mafla Bolanos of Ecuador Finishing First Overall WEST PALM BEACH, FLA. / ACCESS Newswire / December 16, 2025 / U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), proudly celebrated an unforgettable race weekend as first-time Title Sponsor of the 2025 U.S. Polo Assn. Palm Beaches Marathon. The race weekend brought extraordinary energy to Downtown West Palm Beach, powered by more than 6,100 participants, representing 29 countries and 46 states. The race, a Boston Marathon qualifier, was supported by more than 200 dedicated volunteers, including employees from USPA Global, the company that manages the global, multi-billion-dollar U.S. Polo Assn. brand. The U.S. Polo Assn. Palm Beaches Marathon was broadcast live for five hours by the Official Broadcast Station, WPBF 25 (ABC, West Palm Beach). The U.S. Polo Assn. Palm Beaches Marathon was won by Ivan
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders16.12.2025 07:30:00 CET | Press Release
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New Zealand-based intelligence company for brand builders and experience creators. This collaboration marks an exciting step in Market Logic's expansion across APAC, particularly in New Zealand and Australia, where Matter is working closely with local brands that want to deepen their customer and market understanding. Together, Market Logic and Matter will empower APAC businesses to uncover unique insights faster and take swifter action. By combining the power of Market Logic's AI-powered insights platform, DeepSights, with the data, research and measurement expertise of Matter, the two companies will help ambitious local brands drive international growth through intelligence. "New Zealand and Australia are home to exceptional brands who are no strangers to innovation and creativity," said Oliver Allen. "B
AI and Cybersecurity Leader, SecureAuth, Appoints Geoffrey Mattson to Help Enterprises Secure Complex Human, Machine, and AI-agent Identities10.12.2025 17:30:00 CET | Press Release
IRVINE, CALIFORNIA / ACCESS Newswire / December 10, 2025 / SecureAuth, a leader in AI-driven identity security, today announced the appointment of Geoffrey Mattson as Chief Executive Officer. Mattson's appointment marks the beginning of the company's next phase of growth as enterprises confront a rapid rise in AI agents with real authority, a shift that is increasing the complexity of business relationships and driving urgent demand for modern identity security. The Board of Directors thanks outgoing CEO Joseph Dhanapal, who will remain as a strategic advisor. During his tenure, SecureAuth invested heavily in creating a next generation security platform, featuring our market leading, AI-driven risk engine. With this platform in place, SecureAuth is positioned to capture accelerating demand for identity and access management as agentic AI transforms identity from a static access check into a dynamic control plane for managing complex human, machine, and AI-driven relationships. Mattson
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom